In summary, by integrating neuropsychological assessments spanning multiple cognitive domains with genotypic analyses of CD33 SNPs, we identified a pronounced effect of these in individuals afflicted with chronic HBV and HCV – an effect notably absent in Parkinson’s disease individuals. Here, CD33 is linked to Parkinson disease.